银杏达莫联合盐酸倍他司汀注射液治疗椎基底动脉缺血性眩晕的临床研究
[A clinical study on the effect of Yinxing Damo combined with betahistine hydrochloride injection on vertebral basilar artery ischemic vertigo].
作者信息
Deng Yan, Zhu Hai-qing, Deng Guo-bao, Tan Cheng
机构信息
Department of Neurology, the First People's Hospital of Shaoguan, Guangdong 512000, China.
出版信息
Chin J Integr Med. 2005 Sep;11(3):229-31. doi: 10.1007/BF02836511.
OBJECTIVE
To evaluate the therapeutic efficacy of Yinxing Damo (YXDM) combined with Betahistine Hydrochloride Injection (BHI) on vertebra basilar artery ischemic vertigo (VBIV).
METHODS
Ninety patients with VBIV were randomly divided into two groups; 45 patients (the treated group) were treated with YXDM and BHI intravenous dripping, once a day for 14 days. Another 45 patients (control group) were treated with Xueshuantong and BHI intravenous dripping, once daily for 14 days. The clinical syndromes and the index of the transcranial Doppler (TCD) and hemorheology were observed.
RESULTS
The total effective rate was 100% in the treated group, which was better than that in the control group 90.5%, (P < 0.05). The indexes of TCD and hemorheology in the treated group were obviously improved after treatment, (P < 0.01).
CONCLUSION
YXDM combined with BHT injection had better effect in treating patients with VBIV is an ideal drug for VBIV.
目的
评价银杏达莫（YXDM）联合盐酸倍他司汀注射液（BHI）治疗椎基底动脉缺血性眩晕（VBIV）的疗效。
方法
将90例VBIV患者随机分为两组；45例患者（治疗组）采用YXDM和BHI静脉滴注治疗，每日1次，共14天。另外45例患者（对照组）采用血栓通和BHI静脉滴注治疗，每日1次，共14天。观察临床症状以及经颅多普勒（TCD）和血液流变学指标。
结果
治疗组总有效率为100%，优于对照组的90.5%，（P<0.05）。治疗组治疗后TCD和血液流变学指标明显改善，（P<0.01）。
结论
YXDM联合BHT注射液治疗VBIV患者效果较好，是治疗VBIV的理想药物。
Zotero 插件